Cibc World Markets Corp grew its holdings in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 0.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 369,746 shares of the company’s stock after acquiring an additional 2,440 shares during the period. Cibc World Markets Corp owned about 0.30% of Henry Schein worth $25,586,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in HSIC. Versant Capital Management Inc boosted its stake in Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after purchasing an additional 335 shares during the period. Venturi Wealth Management LLC raised its position in shares of Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after buying an additional 569 shares during the last quarter. Quent Capital LLC raised its position in shares of Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after buying an additional 323 shares during the last quarter. Smartleaf Asset Management LLC raised its position in shares of Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after buying an additional 143 shares during the last quarter. Finally, City State Bank bought a new stake in shares of Henry Schein during the fourth quarter valued at approximately $55,000. Institutional investors own 96.62% of the company’s stock.
Analysts Set New Price Targets
HSIC has been the topic of several recent analyst reports. Jefferies Financial Group lifted their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Barrington Research restated an “outperform” rating and issued a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. Wells Fargo & Company initiated coverage on shares of Henry Schein in a research report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price target on the stock. UBS Group reduced their price target on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Finally, Mizuho initiated coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target on the stock. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Henry Schein currently has an average rating of “Moderate Buy” and an average target price of $81.10.
Henry Schein Stock Up 1.1 %
NASDAQ HSIC opened at $70.58 on Monday. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The company has a fifty day moving average of $74.84 and a two-hundred day moving average of $72.62. The firm has a market capitalization of $8.76 billion, a price-to-earnings ratio of 29.05, a PEG ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.49.
Henry Schein (NASDAQ:HSIC – Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). The firm had revenue of $3.19 billion for the quarter, compared to analysts’ expectations of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.66 earnings per share. On average, analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Stories
- Five stocks we like better than Henry Schein
- How to Read Stock Charts for Beginners
- How to Build the Ultimate Everything ETF Portfolio
- Short Selling: How to Short a Stock
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Market Cap Calculator: How to Calculate Market Cap
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.